Video yükleniyor...

Video Yüklenemedi

Bu video yüklenirken bir sorun oluştu. Bu geçici bir ağ sorunundan kaynaklanıyor olabilir veya video kullanılamıyor olabilir.

Ana Sayfaya Dön

One week after planning retirement, Mark was diagnosed with terminal stage four pancreatic cancer. With limited time, he fully committed to change. Two weeks after a profound meditation experience, a PET scan showed no tumor. Two years later, his scans remain clear. “I didn’t cure cancer. I became somebody... show more

Dr Joe Dispenza

255,066 subscribers

152,717 görüntüleme • 6 ay önce •via X (Twitter)

Sağlık & İyilik Bilim & Teknoloji

Anya Rossi• Live Now

Private livecam show

0 Yorum

Yorum bulunmuyor

Orijinal gönderinin yorumları burada görünecek

Benzer Videolar

.Paul S. Conyngham’s dog Rosie was diagnosed with late-stage cancer after vets misdiagnosed her 3 times over 11 months. With no biology background, Paul used AI tools to design her a personalized mRNA cancer vaccine that shrank her tumor by half. He tells the story today on TBPN:

.Paul S. Conyngham’s dog Rosie was diagnosed with late-stage cancer after vets misdiagnosed her 3 times over 11 months. With no biology background, Paul used AI tools to design her a personalized mRNA cancer vaccine that shrank her tumor by half. He tells the story today on TBPN:

TBPN

14,678 görüntüleme • 5 ay önce

🚨 76-YEAR-OLD WITH GLEASON 7 PROSTATE CANCER TAKES IVERMECTIN. 12 WEEKS LATER, PET SCAN SHOWS NOTHING. A doctor shared the story of a 76-year-old veteran who had been diagnosed with Gleason 7 prostate cancer. According to the doctor, the patient began taking 12 mg of Ivermectin daily. After eight weeks, he continued with follow-up testing. At around 12 weeks, he underwent a specialized PET scan looking for abnormalities associated with the prostate. The doctor says the scan could no longer find the cancerous abnormalities. There was another change too. His PSA, which had been 12.6 when the cancer was initially diagnosed, had dropped to 5.3. That is a significant change in the numbers the doctor shared. The story raises an obvious question about the potential role of Ivermectin in prostate cancer, particularly given the growing interest in repurposing older medicines for oncology. Ivermectin is already well established as an antiparasitic medicine, while research into its potential anticancer effects continues to explore mechanisms involving cancer cell growth, survival and signaling. Could Ivermectin deserve a closer look in prostate cancer research?

🚨 76-YEAR-OLD WITH GLEASON 7 PROSTATE CANCER TAKES IVERMECTIN. 12 WEEKS LATER, PET SCAN SHOWS NOTHING. A doctor shared the story of a 76-year-old veteran who had been diagnosed with Gleason 7 prostate cancer. According to the doctor, the patient began taking 12 mg of Ivermectin daily. After eight weeks, he continued with follow-up testing. At around 12 weeks, he underwent a specialized PET scan looking for abnormalities associated with the prostate. The doctor says the scan could no longer find the cancerous abnormalities. There was another change too. His PSA, which had been 12.6 when the cancer was initially diagnosed, had dropped to 5.3. That is a significant change in the numbers the doctor shared. The story raises an obvious question about the potential role of Ivermectin in prostate cancer, particularly given the growing interest in repurposing older medicines for oncology. Ivermectin is already well established as an antiparasitic medicine, while research into its potential anticancer effects continues to explore mechanisms involving cancer cell growth, survival and signaling. Could Ivermectin deserve a closer look in prostate cancer research?

Joe Tippens

31,079 görüntüleme • 2 gün önce

DR. MARK GORDON: "I have a 76-year-old veteran who was diagnosed with a Gleason 7. Gleason is the grade of cancer of the prostate and it was a Gleason 7. He went on 12mg of Ivermectin every day for eight weeks. And at 12 weeks he got a special PET scan done looking at abnormalities in the prostate. They couldn't find anything. And his PSA, when he came in his initial one with the cancer was 12.6. He's now at 5.3."

DR. MARK GORDON: "I have a 76-year-old veteran who was diagnosed with a Gleason 7. Gleason is the grade of cancer of the prostate and it was a Gleason 7. He went on 12mg of Ivermectin every day for eight weeks. And at 12 weeks he got a special PET scan done looking at abnormalities in the prostate. They couldn't find anything. And his PSA, when he came in his initial one with the cancer was 12.6. He's now at 5.3."

Chief Nerd

4,536,555 görüntüleme • 1 yıl önce

Gary Sinise says his son was diagnosed with a 1 in a million spine cancer after his wife was diagnosed with stage 3 breast cancer ‘The week the album went to press,Mac lost his battle with cancer he died on January 5 2024, he was a pure soul a gentle loving kind funny talented guy he loves his sisters he loved his mom she was constantly with him through this fight’ ‘As parent it’s so difficult losing a child I am so blessed fortunate and proud to be his dad’

Gary Sinise says his son was diagnosed with a 1 in a million spine cancer after his wife was diagnosed with stage 3 breast cancer ‘The week the album went to press,Mac lost his battle with cancer he died on January 5 2024, he was a pure soul a gentle loving kind funny talented guy he loves his sisters he loved his mom she was constantly with him through this fight’ ‘As parent it’s so difficult losing a child I am so blessed fortunate and proud to be his dad’

zaza

567,405 görüntüleme • 1 ay önce

🚨 Stage 4 Pancreatic Cancer: From 4 Months to Live to Scheduled for Surgery A man was diagnosed with Stage 4 pancreatic cancer located on the tail of his pancreas, with spread to his liver. He was given only 4 months to live. He began conventional chemotherapy while also following additional protocols. Just weeks later, his scans showed remarkable changes: - No more cancer detected in his liver - His tumor had shrunk from 3.8 cm to 2.2 cm Further testing showed no cancer cells in his abdominal fluid Because of the significant improvement, doctors at MD Anderson scheduled him for distal pancreatectomy surgery on December 16 to remove the remaining tumor. His wife shared that through faith, family support, and consistent treatment, they’ve witnessed what many would consider a miracle. Stories like this continue to give hope to families facing difficult diagnoses. While every case is different, more people are exploring supportive options alongside conventional treatment. If you or a loved one is researching Ivermectin and Fenbendazole as part of a cancer protocol, many people are choosing PharmacyinUSA for clean, pharmaceutical-grade products with worldwide delivery.

🚨 Stage 4 Pancreatic Cancer: From 4 Months to Live to Scheduled for Surgery A man was diagnosed with Stage 4 pancreatic cancer located on the tail of his pancreas, with spread to his liver. He was given only 4 months to live. He began conventional chemotherapy while also following additional protocols. Just weeks later, his scans showed remarkable changes: - No more cancer detected in his liver - His tumor had shrunk from 3.8 cm to 2.2 cm Further testing showed no cancer cells in his abdominal fluid Because of the significant improvement, doctors at MD Anderson scheduled him for distal pancreatectomy surgery on December 16 to remove the remaining tumor. His wife shared that through faith, family support, and consistent treatment, they’ve witnessed what many would consider a miracle. Stories like this continue to give hope to families facing difficult diagnoses. While every case is different, more people are exploring supportive options alongside conventional treatment. If you or a loved one is researching Ivermectin and Fenbendazole as part of a cancer protocol, many people are choosing PharmacyinUSA for clean, pharmaceutical-grade products with worldwide delivery.

PharmacyinUSA

66,621 görüntüleme • 1 ay önce

MUST WATCH: Fmr. Marine Put on Hospice Care After Stage 4 Colo-Rectal Cancer & Three Years of Unsuccessful Chemo Beats His Cancer in a Few Months Using Unexpected Drug "I started doing it 9/2/2021. Six weeks in, keeping in mind I wasn't supposed to make it...what does that scan say? 50% less disease...8 more weeks, I have another scan. No evidence of disease."

MUST WATCH: Fmr. Marine Put on Hospice Care After Stage 4 Colo-Rectal Cancer & Three Years of Unsuccessful Chemo Beats His Cancer in a Few Months Using Unexpected Drug "I started doing it 9/2/2021. Six weeks in, keeping in mind I wasn't supposed to make it...what does that scan say? 50% less disease...8 more weeks, I have another scan. No evidence of disease."

Chief Nerd

5,451,273 görüntüleme • 2 yıl önce

🚨Stage 4 Breast Cancer: No Trace of Disease After 8 Months An 83-year-old woman was diagnosed with terminal Stage 4 breast cancer that had spread to her liver, spine, and bones. Doctors described it as a “Death sentence.” She began taking 222 mg of Fenbendazole daily. After 8 months, her liver enzymes returned to normal, and her tumor markers dropped significantly, from 316 to 36. A follow-up PET scan showed no abnormal metabolic activity, indicating no detectable signs of active cancer. While every case is different and more research is still needed, stories like this continue to generate interest in repurposed medications such as Fenbendazole as part of supportive cancer care. If you or a loved one is exploring Fenbendazole or Ivermectin protocols, many people are choosing GENIX MEDS for clean, pharmaceutical-grade products with worldwide delivery.

🚨Stage 4 Breast Cancer: No Trace of Disease After 8 Months An 83-year-old woman was diagnosed with terminal Stage 4 breast cancer that had spread to her liver, spine, and bones. Doctors described it as a “Death sentence.” She began taking 222 mg of Fenbendazole daily. After 8 months, her liver enzymes returned to normal, and her tumor markers dropped significantly, from 316 to 36. A follow-up PET scan showed no abnormal metabolic activity, indicating no detectable signs of active cancer. While every case is different and more research is still needed, stories like this continue to generate interest in repurposed medications such as Fenbendazole as part of supportive cancer care. If you or a loved one is exploring Fenbendazole or Ivermectin protocols, many people are choosing GENIX MEDS for clean, pharmaceutical-grade products with worldwide delivery.

GENIX MEDS

29,280 görüntüleme • 1 ay önce

No one is worthy of worship. I was recently on Ben Sasse’s Not Dead Yet podcast, and man what a great conversation we had. We talked about faith, family, success and so much more. If you don’t know, back in December Ben was diagnosed with stage four metastasized pancreatic cancer and he started this platform to navigate life with his diagnosis. Super proud of this one and being able to chat with two extraordinary guys! Please give this a listen and show your support:

No one is worthy of worship. I was recently on Ben Sasse’s Not Dead Yet podcast, and man what a great conversation we had. We talked about faith, family, success and so much more. If you don’t know, back in December Ben was diagnosed with stage four metastasized pancreatic cancer and he started this platform to navigate life with his diagnosis. Super proud of this one and being able to chat with two extraordinary guys! Please give this a listen and show your support:

Chris Pratt

366,226 görüntüleme • 3 ay önce

A man diagnosed with stage 4 cancer—over 20 liver metastases—was given little hope. His tumor markers skyrocketed to nearly 1,500. Then, on February 2nd, he began taking Ivermectin—not for cancer, but for COVID. Within two weeks, his CEA levels crashed to 184. Within months, they normalized at 4.7. Over 20 tumors… gone. He believes it wasn’t coincidence, but connection. Chemotherapy destroys both cells and parasites, but what if Ivermectin quietly targets the root cause without annihilating the body? His story forces a question the system refuses to ask: Is modern medicine built to cure—or to keep treating?

A man diagnosed with stage 4 cancer—over 20 liver metastases—was given little hope. His tumor markers skyrocketed to nearly 1,500. Then, on February 2nd, he began taking Ivermectin—not for cancer, but for COVID. Within two weeks, his CEA levels crashed to 184. Within months, they normalized at 4.7. Over 20 tumors… gone. He believes it wasn’t coincidence, but connection. Chemotherapy destroys both cells and parasites, but what if Ivermectin quietly targets the root cause without annihilating the body? His story forces a question the system refuses to ask: Is modern medicine built to cure—or to keep treating?

Camus

138,557 görüntüleme • 9 ay önce

🚨 GIVEN 2 TO 3 YEARS TO LIVE… THEN HER STAGE 4 SCANS CHANGED This woman with metastatic breast cancer says after adding Fenbendazole and later Ivermectin to her integrative protocol, her newest scan showed major changes. Her reported results after ~2.5 months: ✅ Prior spinal cord compression lesion: resolved ✅ Prior S1 spinal involvement: no longer detectable ✅ Suspicious liver lesions: no longer evident ✅ Prior lung nodules: no longer evident Why stories like this spread fast: Because for patients facing advanced cancer, even partial improvement matters. ⚠️ Not a medical advice, consult your doctor before taking any medications. #Ivermectin #Fenbendazole #CancerCure #CancerTreatment Source: Tiktok - fitjeanx_

🚨 GIVEN 2 TO 3 YEARS TO LIVE… THEN HER STAGE 4 SCANS CHANGED This woman with metastatic breast cancer says after adding Fenbendazole and later Ivermectin to her integrative protocol, her newest scan showed major changes. Her reported results after ~2.5 months: ✅ Prior spinal cord compression lesion: resolved ✅ Prior S1 spinal involvement: no longer detectable ✅ Suspicious liver lesions: no longer evident ✅ Prior lung nodules: no longer evident Why stories like this spread fast: Because for patients facing advanced cancer, even partial improvement matters. ⚠️ Not a medical advice, consult your doctor before taking any medications. #Ivermectin #Fenbendazole #CancerCure #CancerTreatment Source: Tiktok - fitjeanx_

PharmacyinUSA

24,859 görüntüleme • 3 ay önce

Corroborating what Gibson reported to Rogan, cancer surgeon Dr. Kathleen Ruddy revealed to The Epoch Times last year that she has seen several late-stage cancer patients make dramatic recoveries after taking Ivermectin. One patient had a grim future, and then something remarkable happened. This man had stage four prostate cancer and tried all the conventional protocols before doctors told him that there was nothing they could do. Then, he started taking ivermectin… Within six months, the metastatic lesions began to disappear, and in less than a year, “he was out dancing for four hours” three nights per week, according to Dr. Ruddy. A similar scenario unfolded for another man named Eddie. He was also in bad shape. Eddie was diagnosed with two unresectable esophageal tumors that surgeons wouldn’t go near. He was a smoker, couldn’t swallow, and had lost 40 pounds in a year and a half. “Within a couple of weeks, he sounded stronger. He could swallow. He had gained six pounds. His voice was better,” reported Dr. Ruddy. Several weeks later, Dr. Ruddy said to Eddie, “You need to get a scan.” Guess what happened? “We got the scan. No tumors. Gone. Gone. The problem was that he had sold his fishing boat. That was the biggest problem. He was getting better. His tumor was gone. Now he’s got to buy another fishing boat … I was like, ‘Well, now, that’s interesting.’”

Corroborating what Gibson reported to Rogan, cancer surgeon Dr. Kathleen Ruddy revealed to The Epoch Times last year that she has seen several late-stage cancer patients make dramatic recoveries after taking Ivermectin. One patient had a grim future, and then something remarkable happened. This man had stage four prostate cancer and tried all the conventional protocols before doctors told him that there was nothing they could do. Then, he started taking ivermectin… Within six months, the metastatic lesions began to disappear, and in less than a year, “he was out dancing for four hours” three nights per week, according to Dr. Ruddy. A similar scenario unfolded for another man named Eddie. He was also in bad shape. Eddie was diagnosed with two unresectable esophageal tumors that surgeons wouldn’t go near. He was a smoker, couldn’t swallow, and had lost 40 pounds in a year and a half. “Within a couple of weeks, he sounded stronger. He could swallow. He had gained six pounds. His voice was better,” reported Dr. Ruddy. Several weeks later, Dr. Ruddy said to Eddie, “You need to get a scan.” Guess what happened? “We got the scan. No tumors. Gone. Gone. The problem was that he had sold his fishing boat. That was the biggest problem. He was getting better. His tumor was gone. Now he’s got to buy another fishing boat … I was like, ‘Well, now, that’s interesting.’”

The Vigilant Fox 🦊

951,001 görüntüleme • 1 yıl önce

AOC: When I was 16 years old, my dad was diagnosed with a very rare form of cancer. His prognosis was not good. The doctors said that with the treatments they had, their options were limited, but there was an experimental trial. For millions across this country—whose child has a rare disease, whose parent is on death’s door, or who themselves have no treatment options—clinical trials are one of the only ways to extend their lives. My dad was admitted to that trial, and his cancer went into remission for a brief period. We got two to three more years with him before he eventually passed away. I can tell you that two more years with my dad, three more years with a child, or a lifetime for those saved by NIH’s work—these people don’t think it’s wasteful. They don’t think what’s happening now is acceptable.

AOC: When I was 16 years old, my dad was diagnosed with a very rare form of cancer. His prognosis was not good. The doctors said that with the treatments they had, their options were limited, but there was an experimental trial. For millions across this country—whose child has a rare disease, whose parent is on death’s door, or who themselves have no treatment options—clinical trials are one of the only ways to extend their lives. My dad was admitted to that trial, and his cancer went into remission for a brief period. We got two to three more years with him before he eventually passed away. I can tell you that two more years with my dad, three more years with a child, or a lifetime for those saved by NIH’s work—these people don’t think it’s wasteful. They don’t think what’s happening now is acceptable.

Acyn

1,276,860 görüntüleme • 1 yıl önce

Megyn Kelly sat down with Dr. Patrick Soon-Shiong to discuss his revolutionary cancer protocol—a treatment that has already extended lives by years for patients with terminal diagnoses, including the late Senator Harry Reid. The Science Behind the Breakthrough Dr. Soon-Shiong’s approach challenges conventional cancer treatments like chemotherapy and radiation, which destroy the immune system’s natural killer (NK) cells and T-cells—critical for fighting cancer. His BioStripe treatment works by rebuilding the immune system, even in patients who have exhausted all other options. Real Patients, Miraculous Results Merkel cell carcinoma (5th-line treatment): Complete remission—patient lived 6+ years and didn’t die from cancer. Bladder cancer: Patients still alive 10-11 years later. Triple-negative breast cancer: Multiple complete remissions. Metastatic pancreatic cancer: One patient disease-free after 5 years, now 6+ years and counting. FDA Roadblocks & Lost Time Despite undeniable success, Dr. Soon-Shiong faced years of resistance from regulators. In 2015, he proposed testing his method before chemo/radiation—but the FDA insisted on starting with end-stage patients. After 700,000 pages of submissions, approval finally came in late 2024. The Future: Beyond Cancer This treatment isn’t just for cancer—it’s showing promise against sepsis and severe infections. One recent case: A Valley Fever patient on a ventilator, given last rites—fully recovered after treatment. The Urgent Question Why is bureaucracy slowing down a therapy that could save millions? With pancreatic cancer, glioblastoma, and lung cancer patients still dying every day, how many more lives could have been saved if this had been fast-tracked?

Megyn Kelly sat down with Dr. Patrick Soon-Shiong to discuss his revolutionary cancer protocol—a treatment that has already extended lives by years for patients with terminal diagnoses, including the late Senator Harry Reid. The Science Behind the Breakthrough Dr. Soon-Shiong’s approach challenges conventional cancer treatments like chemotherapy and radiation, which destroy the immune system’s natural killer (NK) cells and T-cells—critical for fighting cancer. His BioStripe treatment works by rebuilding the immune system, even in patients who have exhausted all other options. Real Patients, Miraculous Results Merkel cell carcinoma (5th-line treatment): Complete remission—patient lived 6+ years and didn’t die from cancer. Bladder cancer: Patients still alive 10-11 years later. Triple-negative breast cancer: Multiple complete remissions. Metastatic pancreatic cancer: One patient disease-free after 5 years, now 6+ years and counting. FDA Roadblocks & Lost Time Despite undeniable success, Dr. Soon-Shiong faced years of resistance from regulators. In 2015, he proposed testing his method before chemo/radiation—but the FDA insisted on starting with end-stage patients. After 700,000 pages of submissions, approval finally came in late 2024. The Future: Beyond Cancer This treatment isn’t just for cancer—it’s showing promise against sepsis and severe infections. One recent case: A Valley Fever patient on a ventilator, given last rites—fully recovered after treatment. The Urgent Question Why is bureaucracy slowing down a therapy that could save millions? With pancreatic cancer, glioblastoma, and lung cancer patients still dying every day, how many more lives could have been saved if this had been fast-tracked?

Camus

615,537 görüntüleme • 1 yıl önce

Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. But the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin has multiple anti-cancer effects. “There are at least nine perfectly defined cancer targets affected by ivermectin,” oncologist Dr. Alfonso Dueñas-González, told The Epoch Times. The news outlet reported: "It [ivermectin] has a broad impact on the immune system, increasing immune offense against cancers." "It also inhibits cancer cell cycles, helping prevent the formation of new cancer cells. The drug promotes the killing of cancer cells by inducing mitochondrial stress and prevents cancer survival by preventing new blood vessels, which transport energy and fuel to cancers, from forming near cancer cells." Dr. Kathleen Ruddy, a cancer surgeon, observed a resounding improvement in three patients under her consultation after they started using ivermectin with additional therapies. One patient, facing terminal stage 4 prostate cancer and given only three weeks to live after all treatments failed, began using ivermectin. Remarkably, within two months, his indicators of prostate cancer plummeted, and by six months, his cancer had significantly receded. Less than a year later, he was energetically dancing for four hours, three nights a week. This miraculous recovery was not isolated, as two more patients experienced similar outcomes. Dr. Ruddy, with over 30 years in cancer surgery, reflected on these cases, saying, “I’ve been a cancer surgeon for over 30 years. I’ve never seen anything like this in one patient—let alone three in a row.” Read the full report in the comment below:

Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. But the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin has multiple anti-cancer effects. “There are at least nine perfectly defined cancer targets affected by ivermectin,” oncologist Dr. Alfonso Dueñas-González, told The Epoch Times. The news outlet reported: "It [ivermectin] has a broad impact on the immune system, increasing immune offense against cancers." "It also inhibits cancer cell cycles, helping prevent the formation of new cancer cells. The drug promotes the killing of cancer cells by inducing mitochondrial stress and prevents cancer survival by preventing new blood vessels, which transport energy and fuel to cancers, from forming near cancer cells." Dr. Kathleen Ruddy, a cancer surgeon, observed a resounding improvement in three patients under her consultation after they started using ivermectin with additional therapies. One patient, facing terminal stage 4 prostate cancer and given only three weeks to live after all treatments failed, began using ivermectin. Remarkably, within two months, his indicators of prostate cancer plummeted, and by six months, his cancer had significantly receded. Less than a year later, he was energetically dancing for four hours, three nights a week. This miraculous recovery was not isolated, as two more patients experienced similar outcomes. Dr. Ruddy, with over 30 years in cancer surgery, reflected on these cases, saying, “I’ve been a cancer surgeon for over 30 years. I’ve never seen anything like this in one patient—let alone three in a row.” Read the full report in the comment below:

The Vigilant Fox 🦊

1,192,290 görüntüleme • 2 yıl önce

Callum McNeill started his pro career after Hal Sutton said he would help him if Cal quit his job and fully committed. 4 years later, and now with a family, Cal was giving Q-school one more try. And he advanced to final stage. I spoke with him about Hal and Q-school. Links ⬇️

Callum McNeill started his pro career after Hal Sutton said he would help him if Cal quit his job and fully committed. 4 years later, and now with a family, Cal was giving Q-school one more try. And he advanced to final stage. I spoke with him about Hal and Q-school. Links ⬇️

Monday Q Info

26,501 görüntüleme • 8 ay önce

At just 62 years old, Rick Jennings was given 2.5 years to live, after being diagnosed with bone marrow cancer — unless he found a matching donor for stem cells. Enter Ryan Menninga, a Division 1 swimmer in his senior year at the University of Wisconsin-Milwaukee. Ryan, who had signed up to become a stem cell donor, found out he was an anonymous match for a man in need, who turned out to be Rick. Years later, after the two were connected through the National Marrow Donor Program, Rick, now cancer-free, was able to surprise Ryan on his wedding day, so he could offer an official thank you for Ryan’s kindness.

At just 62 years old, Rick Jennings was given 2.5 years to live, after being diagnosed with bone marrow cancer — unless he found a matching donor for stem cells. Enter Ryan Menninga, a Division 1 swimmer in his senior year at the University of Wisconsin-Milwaukee. Ryan, who had signed up to become a stem cell donor, found out he was an anonymous match for a man in need, who turned out to be Rick. Years later, after the two were connected through the National Marrow Donor Program, Rick, now cancer-free, was able to surprise Ryan on his wedding day, so he could offer an official thank you for Ryan’s kindness.

CBS Mornings

12,384 görüntüleme • 5 ay önce

A New Dawn in the Cancer War: Pioneering "BioShield" Technology Achieves Long-Term Remission Where Others Failed A stunning revelation from Dr. Patrick Soon-Shiong on the dawn of a new medical era. He details a breakthrough he calls "BioShield," a technology designed to prevent cancer by fundamentally educating the body's own immune system. Forget conventional vaccines. This isn't about antibodies. This is about creating a living, intelligent defense system within you. Here’s the concept: "BioShield" educates your T-cells to become elite "memory" cells. They then hide in your bone marrow, lying in wait. When a cancerous cell appears, they emerge to seek and destroy it—stopping cancer before it can ever gain a foothold. This isn't science fiction. It's peer-reviewed, published science with the National Cancer Institute (NCI). And the results are nothing short of remarkable: ➡️ Bladder Cancer: Patients who failed all other treatments and faced radical bladder removal have achieved complete remission for nine years after a simple injection. No surgery. Just a functional cure. ➡️ Pancreatic Cancer: A disease with a grim prognosis, now seeing patients disease-free for five years. The late Senator Harry Reid, after being told by others not to pursue it, saw his tumor markers normalize and lived two active, cancer-free years. ➡️ Merkel Cell Carcinoma & Head/Neck Cancer: Stories of complete responses in patients given weeks to live, with one living nine years and another saved from hospice when his ulcerating tumor melted away. Dr. Soon-Shiong is reframing the conversation. This isn't a "vaccine" in the traditional sense. It's Project BioShield—a proactive, cellular guardian for the body. The takeaway? We are transitioning from toxic, reactive cancer therapies to intelligent, preemptive protection. The age of the immune system as our most powerful shield against cancer has arrived. What are your thoughts on this "BioShield" approach to cancer?

A New Dawn in the Cancer War: Pioneering "BioShield" Technology Achieves Long-Term Remission Where Others Failed A stunning revelation from Dr. Patrick Soon-Shiong on the dawn of a new medical era. He details a breakthrough he calls "BioShield," a technology designed to prevent cancer by fundamentally educating the body's own immune system. Forget conventional vaccines. This isn't about antibodies. This is about creating a living, intelligent defense system within you. Here’s the concept: "BioShield" educates your T-cells to become elite "memory" cells. They then hide in your bone marrow, lying in wait. When a cancerous cell appears, they emerge to seek and destroy it—stopping cancer before it can ever gain a foothold. This isn't science fiction. It's peer-reviewed, published science with the National Cancer Institute (NCI). And the results are nothing short of remarkable: ➡️ Bladder Cancer: Patients who failed all other treatments and faced radical bladder removal have achieved complete remission for nine years after a simple injection. No surgery. Just a functional cure. ➡️ Pancreatic Cancer: A disease with a grim prognosis, now seeing patients disease-free for five years. The late Senator Harry Reid, after being told by others not to pursue it, saw his tumor markers normalize and lived two active, cancer-free years. ➡️ Merkel Cell Carcinoma & Head/Neck Cancer: Stories of complete responses in patients given weeks to live, with one living nine years and another saved from hospice when his ulcerating tumor melted away. Dr. Soon-Shiong is reframing the conversation. This isn't a "vaccine" in the traditional sense. It's Project BioShield—a proactive, cellular guardian for the body. The takeaway? We are transitioning from toxic, reactive cancer therapies to intelligent, preemptive protection. The age of the immune system as our most powerful shield against cancer has arrived. What are your thoughts on this "BioShield" approach to cancer?

Camus

31,209 görüntüleme • 8 ay önce

Three Cancer Patients Defy Odds with Ivermectin: A Doctor’s Call for Urgent Research Dr. Kathleen Ruddy, a breast cancer surgeon, author, and inventor, shared remarkable stories of three patients with advanced, aggressive cancers who chose ivermectin based on their own research, yielding astonishing outcomes that raise urgent questions about repurposed drugs in oncology. The first, Paul Mann, a 53-year-old marathoner from Phoenix with no family history of cancer, was diagnosed with stage 4 prostate cancer two months after his second Pfizer vaccine. Given three weeks to live, with hospice called, Paul started ivermectin. Slowly, his condition improved; today, he dances four hours a night, three nights a week. His tumor hasn’t fully regressed, but he’s exploring other repurposed medications, a far cry from his initial prognosis. The second patient, Eddie, a man in his late 60s, had unresectable esophageal carcinoma with two inoperable tumors. Declining chemo and radiation, he took ivermectin alone. Within six weeks, his tumors vanished completely, with no other treatment. The third, a woman with an 18cm pelvic tumor originating from her stomach lining, faced grim odds. After a remarkable surgical resection, liver metastases remained. Post-op, she chose ivermectin, and her liver metastases cleared entirely. Dr. Ruddy cautions that three patients aren’t a clinical trial, but three consecutive, dramatic responses in such dire cases are striking. She believes “there’s something going on here that looks important.” Frustrated by the pharmaceutical industry’s disinterest, as well as the lack of support from academic institutions and philanthropies—none of whom she expects to fund ivermectin research due to its low cost—she’s strategizing a scientifically sound, ethical approach to study whether ivermectin and other repurposed drugs can improve cancer survival. These anecdotes aren’t definitive evidence but compel us to ask: could repurposed drugs hold untapped potential for cancer treatment? Rigorous research is needed to find out.

Three Cancer Patients Defy Odds with Ivermectin: A Doctor’s Call for Urgent Research Dr. Kathleen Ruddy, a breast cancer surgeon, author, and inventor, shared remarkable stories of three patients with advanced, aggressive cancers who chose ivermectin based on their own research, yielding astonishing outcomes that raise urgent questions about repurposed drugs in oncology. The first, Paul Mann, a 53-year-old marathoner from Phoenix with no family history of cancer, was diagnosed with stage 4 prostate cancer two months after his second Pfizer vaccine. Given three weeks to live, with hospice called, Paul started ivermectin. Slowly, his condition improved; today, he dances four hours a night, three nights a week. His tumor hasn’t fully regressed, but he’s exploring other repurposed medications, a far cry from his initial prognosis. The second patient, Eddie, a man in his late 60s, had unresectable esophageal carcinoma with two inoperable tumors. Declining chemo and radiation, he took ivermectin alone. Within six weeks, his tumors vanished completely, with no other treatment. The third, a woman with an 18cm pelvic tumor originating from her stomach lining, faced grim odds. After a remarkable surgical resection, liver metastases remained. Post-op, she chose ivermectin, and her liver metastases cleared entirely. Dr. Ruddy cautions that three patients aren’t a clinical trial, but three consecutive, dramatic responses in such dire cases are striking. She believes “there’s something going on here that looks important.” Frustrated by the pharmaceutical industry’s disinterest, as well as the lack of support from academic institutions and philanthropies—none of whom she expects to fund ivermectin research due to its low cost—she’s strategizing a scientifically sound, ethical approach to study whether ivermectin and other repurposed drugs can improve cancer survival. These anecdotes aren’t definitive evidence but compel us to ask: could repurposed drugs hold untapped potential for cancer treatment? Rigorous research is needed to find out.

Camus

38,022 görüntüleme • 1 yıl önce

🚨 STAGE 4 BREAST CANCER. HOSPICE CARE. EIGHT MONTHS LATER, THE PET SCAN SHOCKED EVERYONE. A 33-year-old woman was facing a devastating diagnosis. Her breast cancer had returned. And this time it had spread. 📌 Liver 📌 Lungs 📌 Spine 📌 Pelvis 📌 Multiple vertebrae 📌 Bones A liver biopsy confirmed metastatic breast cancer. MRI scans showed cancer throughout her spine and skeletal system. PET scans revealed multiple hypermetabolic lung and bone lesions. The disease was widespread. By late 2021, she declined further conventional chemotherapy and was placed under hospice care. For many patients, that's where the story ends. But in November 2021, she began taking 222mg of Fenbendazole daily. At the start: • Cancer was confirmed in her liver • Cancer was confirmed in her bones • Multiple lung lesions were present • Tumor marker CA27.29 measured 316 Over the next several months, she continued taking 222mg of Fenbendazole daily. Then something remarkable happened. ✅ Liver enzymes returned to normal ✅ Tumor marker CA27.29 dropped from 316 to 36.6 ✅ Pain from spinal metastases improved And then came the PET scan. In April 2022, follow-up imaging reportedly showed no abnormal metabolic activity indicative of cancer. Think about that. The previous scans had shown active disease in the liver, lungs, spine, pelvis, and bones. Months later, the PET scan reportedly found no evidence of abnormal cancer activity. Cases like this are why Fenbendazole continues to attract attention around the world. Not because of opinions. Because people are looking at scans. Looking at lab results. Looking at outcomes. And deciding for themselves what questions deserve answers. 💊 Looking for Fenbendazole, Ivermectin, or Mebendazole? Explore RXMEDS.STORE. #Fenbendazole #BreastCancer #CancerResearch #RepurposedDrugs #Oncology #RxMeds

🚨 STAGE 4 BREAST CANCER. HOSPICE CARE. EIGHT MONTHS LATER, THE PET SCAN SHOCKED EVERYONE. A 33-year-old woman was facing a devastating diagnosis. Her breast cancer had returned. And this time it had spread. 📌 Liver 📌 Lungs 📌 Spine 📌 Pelvis 📌 Multiple vertebrae 📌 Bones A liver biopsy confirmed metastatic breast cancer. MRI scans showed cancer throughout her spine and skeletal system. PET scans revealed multiple hypermetabolic lung and bone lesions. The disease was widespread. By late 2021, she declined further conventional chemotherapy and was placed under hospice care. For many patients, that's where the story ends. But in November 2021, she began taking 222mg of Fenbendazole daily. At the start: • Cancer was confirmed in her liver • Cancer was confirmed in her bones • Multiple lung lesions were present • Tumor marker CA27.29 measured 316 Over the next several months, she continued taking 222mg of Fenbendazole daily. Then something remarkable happened. ✅ Liver enzymes returned to normal ✅ Tumor marker CA27.29 dropped from 316 to 36.6 ✅ Pain from spinal metastases improved And then came the PET scan. In April 2022, follow-up imaging reportedly showed no abnormal metabolic activity indicative of cancer. Think about that. The previous scans had shown active disease in the liver, lungs, spine, pelvis, and bones. Months later, the PET scan reportedly found no evidence of abnormal cancer activity. Cases like this are why Fenbendazole continues to attract attention around the world. Not because of opinions. Because people are looking at scans. Looking at lab results. Looking at outcomes. And deciding for themselves what questions deserve answers. 💊 Looking for Fenbendazole, Ivermectin, or Mebendazole? Explore RXMEDS.STORE. #Fenbendazole #BreastCancer #CancerResearch #RepurposedDrugs #Oncology #RxMeds

RXMEDS.STORE

16,476 görüntüleme • 2 ay önce

One of my best friends finally lost his battle with cancer overnight. For 27+ years he was my right hand man and I thank God for him, because he was a better friend than I ever deserved. I'm heartbroken but at the same time grateful he's no longer suffering. RIP, Ryan

One of my best friends finally lost his battle with cancer overnight. For 27+ years he was my right hand man and I thank God for him, because he was a better friend than I ever deserved. I'm heartbroken but at the same time grateful he's no longer suffering. RIP, Ryan

Patrick Moran (Talking Buffalo)

18,799 görüntüleme • 4 ay önce